Generating evidence for optimal market access – an Executive Interview with Jeff Anderson and Rosemary Jose, OPEN Health

Jeff Anderson is CEO of the Evidence & Access practice and Rosemary Jose leads Strategic Market Access strategy and activities. They talk about current dynamics in the healthcare industry and the challenges of generating evidence for optimal market access. Continue Reading

Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD

Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic steatohepatitis), has become a major public health concern, affecting about one in four Americans (Younossie 2018). Its increasing prevalence parallels rising rates of obesity and type 2 diabetes. Continue Reading

Using AI, NLP and Data Visualization with RWE to Generate Insights into Care Gaps: Retrospective Cohort Analysis of Fracture Risk in Patients with Osteopenia and Osteoporosis

This blog reports practical uses of RWD sourced from the largest, cloud-based electronic health record (EHR) platform in the United States, offered by Veradigm® as part of its Health Insights database. Continue Reading

Tackling Rare Diseases with an Arsenal of Real-World Data

Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations — getting down to ever more precise groups of likely responders to therapy, high-risk patients and other high-value subphenotypes. Continue Reading

How Artificial Intelligence and Real World Data Can Improve the Management of Type 2 Diabetes: A Case Study

See how Veradigm, a business unit of Allscripts focused on generating data-driven healthcare insights using EHR data applied artificial intelligence to EHRs to improve therapeutic management of patients with concordant comorbidities who are living with type 2 diabetes. Continue Reading